67547EGP
- Active ingredient
- ramucirumab
- Strength
- 500 mg/50ml
- Form
- vial
- Manufacturer
- eli lilly
- Route
- injection
Uses
Used in the treatment of several advanced cancers including gastric, colorectal, lung, and hepatocellular carcinoma in specific settings.
Do not use if
No absolute contraindications are widely established; hypersensitivity to the product should be avoided.
Side effects
May cause hypertension, fatigue, diarrhea, bleeding, proteinuria, and infusion-related reactions.
Warnings
Monitor for bleeding, hypertension, gastrointestinal perforation, and impaired wound healing.
How it works
Monoclonal antibody that binds VEGF receptor-2 and inhibits tumor angiogenesis.
Storage
Store refrigerated at 2–8°C. Do not freeze.
